Cem Yalcinkaya博士は、アナドル医療センターの准教授であり、婦人科腫瘍専門医です。妊孕性温存手術および婦人科がんに対するロボット手術を専門としています。Yalcinkaya博士は、ダヴィンチ・システムにおけるロボット手術の認定資格を保持しています。2019年には、欧州婦人科腫瘍学会（ESGO）の試験に合格しました。
ジョルディ・アントニ・ビベス医師は、Teknogin（バルセロナ、Centro Médico Teknon）の産婦人科専門医です。婦人科腫瘍外科、複雑な子宮および骨盤病理、腫瘍委員会（Tumor Board）の調整に注力しています。2015年よりCIMA病院の産科部門を率いています。1990年よりParc Taulíのコンサルタント医師を務めています。
教育・認定：バルセロナ大学医学・外科学位（1983年）。産婦人科MIRレジデンシー（1990年）。欧州大学婦人科手術内視鏡学上級ディプロマ（2000年）。ダヴィンチロボット手術認定（2010年）。メイヨークリニック（スコッツデール）での研修（1994年および1999年）。
リーダーシップ・所属・受賞歴：Parc Taulíの婦人科腫瘍機能ユニットおよび腫瘍委員会のコーディネーター兼会長。スペイン、カタルーニャ、欧州の産婦人科学会、およびGEICO子宮頸がん委員会のメンバー。バルセロナ公式医師会産婦人科部門会長。専門職優秀賞（2015年）およびTop Doctors Awards 2016受賞。
オマール医師は低侵襲手術を専門とし、オックスフォード大学とハーバード大学で高度な学位を取得しています。針を使わないIVF（体外受精）のパイオニアとして、不妊治療中の患者の不快感を軽減しています。
Yeoun E Park医師は、ソウルミズ病院の病院長兼最高医療責任者です。子宮筋腫および卵巣腫瘍の腹腔鏡下手術を専門としています。Park医師は、失禁および女性美容外科クリニックも管理しています。韓国大学および翰林大学の医学部で非常勤教授を務めています。
当医師は、30年以上の臨床経験を持つ産婦人科の非常に経験豊富な専門医です。1994年以来、バルセロナのCentro Médico Teknonの医療スタッフの主要メンバーであり、現在は産婦人科の診療部長を務めています。臨床的な専門分野は、不妊症の診断、生殖補助医療技術、体外受精（IVF）の計画、包括的な妊娠モニタリング、出産ケア、出生前診断など多岐にわたります。
婦人科超音波検査および更年期障害の管理における豊富な専門知識に加え、スペイン産婦人科学会から産婦人科超音波検査のレベルIIIトレーニングディプロマを取得しています。
当医師は、治癒的ケアおよび緩和ケアを含む、あらゆる臨床段階の乳がんを専門とする高度な資格を持つ腫瘍内科医です。エクアドル・ポンティフィシア・カトリック大学で医学の学位を取得し、サンタ・クレウ・イ・サン・パウ病院で5年間の研修を修了後、スペイン腫瘍内科学会（SEOM）の腫瘍内科修士号を取得しています。
現在は国際乳がんセンター（IBCC）およびバルセロナのIOB腫瘍学研究所で勤務しており、第I相臨床試験および研究において豊富な経験を有しています。臨床専門分野は、神経内分泌腫瘍、婦人科がん、非小細胞肺がんに対する免疫療法にまで及びます。SEOMおよびESMOの正会員です。
Kevser Arkan医師（MD）は、チョルルおよびチェルケズキョイにあるOPTIMED Health Groupの婦人科腫瘍外科（産婦人科）のサブスペシャリストです。2026年から同グループに勤務しています。英語とトルコ語で診療を行っています。
臨床的な専門分野は、卵巣がん、子宮内膜がん、子宮頸がんの外科的管理です。根治的子宮全摘出術、センチネルリンパ節マッピングを伴うリンパ節郭清、腫瘍減量術など、複雑な骨盤内手術を行います。vNOTES（傷跡のない腹腔鏡手術）、腹腔鏡手術、開腹手術、子宮鏡手術などの低侵襲手術を提供しています。また、仙骨膣固定術を含む泌尿器婦人科的再建術も行っています。ハイリスク妊娠の管理も行います。
資格：医学博士、ガズィアンテプ大学（2016年）。産婦人科レジデンシー、カフラマンマラシュ・スチュ・イマム大学（2016–2021年）。婦人科腫瘍外科フェローシップ、ディヤルバクル・ガズィ・ヤシャルギル教育研究病院（2022–2025年）。経験：ディヤルバクル母子病院、婦人科腫瘍クリニック（2022–2025年）。アドゥヤマン・カフタ州立病院（2021–2022年）。ギレスン・アルクラTSM（2016年）。
学術活動：2025年には、vNOTESを用いた子宮内膜がん病期分類におけるセンチネルリンパ節マッピングに関する査読付き研究や、vNOTESと腹腔鏡手術の比較結果に関する研究を発表しました。また、骨盤臓器脱と性機能、GTN葉酸レジメン、vNOTES支援による仙骨膣固定術についても報告しています。彼女の論文は、BMC Surgery、Scientific Reports、Journal of Clinical Medicine、Ginekologia Polskaなどのジャーナルに掲載されています。
フォーブス誌によりスペインの一般外科医トップ5に選出されたカナーレス医師は、ルベル・インターナショナル病院のロボット手術ユニットを率いています。
ミハイル・バナク医師は、ポンデラス・アカデミック病院にて、複雑な婦人科疾患、特に子宮内膜症を専門としています。
2つのロボットプラットフォームを使用して手術を行う認定をSERGSから受けた、世界初の婦人科医です。スタンチュ医師は、ポンデラス・アカデミック病院にて複雑な低侵襲手術を行っています。
Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.
1980–1985: Completed doctoral studies at Nagasaki University, Japan
1968–present: Department of Radiology, Chinese PLA General Hospital
1988: Third Prize of the Military Science and Technology Progress Award
1989–present: Member of Radiological Society of North America(RSNA)
1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA
1991: Second Prize of the Military Science and Technology Progress Award
1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology
1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology
1993: Granted the Lifetime Special Government Allowance of the State Council
1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology
1994: Third Prize of the Military Science and Technology Progress Award
1997: Second Prize of the Military Science and Technology Progress Award
1997–2009: Standing Member of Chinese Society of Radiology
1999: Third Prize of the Military Science and Technology Progress Award
1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology
2002: Second Prize of the Military Science and Technology Progress Award
2005: Third Prize of the Military Science and Technology Progress Award
Member of Radiological Society of North America(RSNA)
Standing Member of Chinese Society of Radiology
Group Leader of the Group of Intervention of Chinese Journal of Radiology
Deputy Director Member of Chinese Society of Interventional Oncology
Director Member of Beijing Medical Association Society of Interventional Radiology
Deputy Chief Editor of Chinese Journal of Medical Image Technology
Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army
Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology
Awarded the Special Government Allowance of the State Council
Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.
Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”
Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.
In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.
Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.
In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.
Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.
From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.
Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.
1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.
Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.
2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.
Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.
3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.
Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.
4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.
Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.
5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.
Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.
6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.
Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.
7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.
Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.
8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.
Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.
1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.
2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.
3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.
1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.
2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.
3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.
4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.
アブドラ・サキン教授（Prof. Dr. Abdullah Sakin）は、腫瘍内科の教授です。肺がん、乳がん、消化器がん、泌尿器がん、婦人科がん、頭頸部がん、悪性黒色腫（メラノーマ）などの固形腫瘍を専門としています。
科学的根拠に基づいた個別化医療を提供しています。治療法には、化学療法、分子標的療法、免疫療法、ホルモン療法、精密腫瘍学（プレシジョン・オンコロジー）が含まれます。200本以上の科学論文を執筆しており、国際的な臨床研究にも積極的に参加しています。これらの活動は、患者中心のがん医療の発展に寄与しています。
Gül Alço教授は、約27年の経験を持つ放射線腫瘍医です。乳がん、肺がん、前立腺がん、消化器がん、婦人科がん、中枢神経系腫瘍、頭頸部がん、軟部組織腫瘍、骨腫瘍の放射線治療を行っています。
専門分野は、適応放射線治療とラジオサージャリー（放射線外科）です。高度な放射線技術を駆使し、患者中心の多職種連携環境において、個別化された科学的根拠に基づくケアを提供しています。
| 順位 | 医師 | 経験 | 適合する方 | 特色 | クリニックと所在地 | 診察 |
|---|---|---|---|---|---|---|
| #1 | 9年の経験 | 低侵襲な不妊治療 | 患者の不快感を軽減する針を使わないIVFのパイオニア。生殖補助医療および生殖内分泌学において、オックスフォード大学とハーバード大学の高度な学位を保持。 | エジプト | お問い合わせください | |
| #2 | 76年の経験 | 複雑なロボット支援下子宮全摘出術 | スペインで最高評価を受けるロボット外科医であり、ダヴィンチ・システムを備えたルベル・インターナショナルの専門ユニットを統括。フォーブス誌の国内ベスト外科医リストに名を連ね、コンプルテンセ大学で教鞭をとる。 | スペイン | から €390 | |
| #3 | 15年の経験 | 複雑な子宮内膜症の症例 | 複雑な婦人科疾患、特に子宮内膜症を専門としています。ポンデラス・アカデミック病院の多職種チームと連携し、個別化された治療計画を策定します。 | ルーマニア | お問い合わせください | |
| #4 | 11年の経験 | 複雑なロボット支援下子宮全摘術 | SERGSにより2つのロボットプラットフォームの認定を受けた世界初の婦人科医。高度な低侵襲技術を用いた妊孕性温存がん手術を専門としています。 | ルーマニア | お問い合わせください |